Cargando…
Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors
Adrenocortical carcinomas (ACCs) are complex neoplasias that may present unexpected clinical behavior, being imperative to identify new biological markers that can predict patient prognosis and provide new therapeutic options. The main aim of the present study was to evaluate the prognostic value of...
Autores principales: | Pinheiro, Céline, Granja, Sara, Longatto-Filho, Adhemar, Faria, André M., Fragoso, Maria C. B. V., Lovisolo, Silvana M., Lerário, Antonio M., Almeida, Madson Q., Baltazar, Fátima, Zerbini, Maria C. N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792565/ https://www.ncbi.nlm.nih.gov/pubmed/26587828 |
Ejemplares similares
-
GLUT1 expression in pediatric adrenocortical tumors: a promising candidate to predict clinical behavior
por: Pinheiro, Céline, et al.
Publicado: (2017) -
Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy
por: Afonso, Julieta, et al.
Publicado: (2023) -
Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma
por: de Sousa, Gabriela Resende Vieira, et al.
Publicado: (2015) -
Expression of Monocarboxylate Transporters 1, 2, and 4 in Human Tumours and Their Association with CD147 and CD44
por: Pinheiro, Céline, et al.
Publicado: (2010) -
Reprogramming energy metabolism and inducing angiogenesis: co-expression of monocarboxylate transporters with VEGF family members in cervical adenocarcinomas
por: Pinheiro, Céline, et al.
Publicado: (2015)